loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 209830 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ARIPIPRAZOLE LAUROXIL (1)

filter

01 ALKERMES INC (1)

filter

01 SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (1)

filter

01 675MG/2.4ML (281.25MG/ML) (1)

filter

01 USA (1)

URL Supplier Web Content
SUSPENSION, EXTENDED R...
675MG/2.4ML (281.25MG/...
ARISTADA INITIO KIT
USA
209830
2018-06-29
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 209830

Looking for CTD TGA MCC DOSSIER APPLICATION 209830 1

19

Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 209830 and regulatory information .

proudly manufactured in the

approval since 2018-06-29

Alkermes Plc's ARISTADA INITIO KIT SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 675MG/2.4ML (281.25MG/ML) of ARIPIPRAZOLE LAUROXIL.

Post Enquiry
POST ENQUIRY